Sep. 8 at 4:24 PM
$SDGR It's pretty clear that SMID bios are fucked. As we head into a recession, we should finally see hundreds of them go bankrupt. This will be the coup de grace. And we have a government sitting idle while China kicks our ass in biotech.
China-sourced assets will make up almost 40% of all licensing deals this year, up from less than 3% five years ago, and 30% last year.
Meanwhile, Trump/FRK stir anti-science paranoia and cut research funding. It's almost like they themselves are Chinese assets!
This has a direct impact on SDGR's business. The Big Pharmas are their only real customers at this point. And they are fickle. All it takes is one big customer to bail on their arrangement (like BMY did) and this stock will collapse to
$12.
I had high hopes when I bought in three years ago. I wouldn't say I have no hopes now, but I will short any near or intermediate term upside.
